Also trades as: TEVA (NYSE) · $vol 221M · TEVA.TA (TLV) · $vol 41M

$38.98

+1.98 (+5.35%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 64 · $45.4B mcap · 1.11B float · 0.0000% daily turnover · Short 88% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Income Trends

Revenue

$18.7B +12.9% ▲

5Y CAGR: +2.3%

Gross Profit

$9.6B +19.5% ▲

5Y CAGR: +4.5%

Operating Income

$4.3B +1511.9% ▲

Net Income

$1.5B +193.2% ▲

EPS (Diluted)

$1.31 +190.3% ▲

EBITDA

$3.4B +340.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$15.9B	$14.9B	$15.8B	$16.5B	$18.7B
YoY Growth	-4.7%	-6.0%	+6.2%	+4.4%	+12.9%
Cost of Revenue	$8.3B	$8.0B	$8.2B	$8.5B	$9.0B
Gross Profit	$7.6B	$7.0B	$7.6B	$8.1B	$9.6B
Gross Margin	47.8%	46.7%	48.3%	48.7%	51.6%
R&D Expenses	$967M	$838M	$1.0B	$998M	$1.1B
SG&A Expenses	$3.5B	$3.4B	$3.5B	$3.7B	$4.0B
Operating Expenses	$4.5B	$4.3B	$7.2B	$8.4B	$5.4B
Operating Income	$1.7B	-$2.1B	$433M	-$303M	$4.3B
Operating Margin	10.8%	-14.1%	2.7%	-1.8%	22.9%
Interest Expense	$1.1B	$966M	$1.0B	$1.0B	$1.0B
Income Before Tax	$658M	-$3.1B	-$622M	-$1.3B	$1.3B
Tax Expense	$211M	-$638M	-$7M	$676M	-$195M
Net Income	$417M	-$2.4B	-$559M	-$1.6B	$1.5B
Net Margin	2.6%	-15.8%	-3.5%	-9.9%	8.2%
EPS (Diluted)	$0.38	$-2.12	$-0.50	$-1.45	$1.31
EBITDA	$2.9B	-$925M	$1.6B	$777M	$3.4B
Shares Outstanding	1.11B	1.11B	1.12B	1.13B	1.16B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$4.3B	$4.2B	$3.9B	$4.2B	$4.5B	$4.7B	$4.0B	$4.1B
Cost of Revenue	$2.2B	$2.1B	$2.0B	$2.1B	$2.2B	$2.1B	$2.0B	$2.0B
Gross Profit	$2.1B	$2.1B	$1.9B	$2.1B	$2.3B	$2.7B	$2.0B	$2.2B
Gross Margin	49.6%	50.1%	48.2%	50.3%	51.4%	56.4%	49.5%	52.0%
R&D Expenses	$240M	$247M	$247M	$244M	$256M	$267M	$222M	$970M
SG&A Expenses	$924M	$952M	$919M	$959M	$973M	$1.1B	$1.0B	$1.0B
Operating Expenses	$2.2B	$2.1B	$1.4B	$1.6B	$1.4B	$1.4B	$1.3B	$2.4B
Operating Income	-$51M	-$29M	$519M	$455M	$882M	$1.3B	$652M	-$231M
Operating Margin	-1.2%	-0.7%	13.3%	10.9%	19.7%	27.5%	16.4%	-5.6%
Interest Expense	$272M	$239M	$225M	$203M	$209M	$27M	$214M	$262M
Income Before Tax	-$321M	-$247M	$294M	$203M	$648M	$93M	$434M	-$455M
Tax Expense	$69M	$28M	$74M	-$78M	$214M	-$397M	$67M	$121M
Net Income	-$437M	-$217M	$214M	$282M	$433M	$490M	$369M	-$576M
Net Margin	-10.1%	-5.1%	5.5%	6.8%	9.7%	10.4%	9.3%	-13.9%
EPS (Diluted)	$-0.39	$-0.19	$0.18	$0.24	$0.37	$0.42	$0.31	$-0.49
EBITDA	$207M	$261M	$763M	$657M	$1.1B	$463M	$1.0B	$408M
Shares Outstanding	1.13B	1.13B	1.16B	1.16B	1.16B	1.17B	1.18B	1.18B

TEVJF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet